## **Core Concept**
The question tests knowledge of antineoplastic agents and their side effects, specifically cardiotoxicity. Antineoplastic agents, also known as chemotherapeutic agents, are used to treat cancer. Cardiotoxicity is a significant side effect of certain chemotherapeutic agents, leading to potential heart damage.

## **Why the Correct Answer is Right**
Doxorubicin is an anthracycline antibiotic that intercalates DNA strands, thereby inhibiting the synthesis of macromolecules and inducing apoptosis in cancer cells. However, one of its major side effects is cardiotoxicity, which can lead to congestive heart failure. This cardiotoxicity is dose-dependent and can be irreversible. The mechanism involves the generation of free radicals, which damage cardiac myocytes.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Although some antineoplastic agents have specific toxicities, without the actual drug names provided, we can't directly assess their accuracy. However, given that doxorubicin is well-known for cardiotoxicity, any other option would need to be evaluated based on its side effect profile.
* **Option B:** Similarly, without specifics, we can't directly refute, but we know certain drugs have hepatotoxicity, neurotoxicity, or myelosuppression as notable side effects.
* **Option C:** This could potentially be another cardiotoxic agent, but doxorubicin is notably recognized for this side effect.
* **Option D:** Without specifics, it's hard to directly address, but given doxorubicin's notable cardiotoxicity, options not directly implicating doxorubicin are less likely to be correct.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that doxorubicin's cardiotoxicity can be monitored by measuring left ventricular ejection fraction (LVEF) before and during treatment. Dose limitation and the use of cardioprotective agents like dexrazoxane can help mitigate this risk.

## **Correct Answer:** . Doxorubicin